Last reviewed · How we verify

NCT04749823: NEXERCISE

The NEXERCISE-trial: Reshaping Exercise Programs for Patients With Non-specific Neck Pain

Completed NA Last updated 11 January 2024
What this trial tests

NA trial testing Blended treatment program in Neck Pain in 48 participants. Completed in 1 September 2022.

Timeline
1 March 2021
Primary endpoint
1 September 2022
1 September 2022

Quick facts

Lead sponsorUniversity Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment48
Start date1 March 2021
Primary completion1 September 2022
Estimated completion1 September 2022
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Ghent

Who can join

Adults 18 to 65, any sex, with Neck Pain or Chronic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Nexercise-trial is a blended treatment program for patients with chronic non-specific neck pain. We will investigate whether a blended treatment approach, combining specific neck exercises and general aerobic exercises, has better outcome (on medical impact for the patient and socio-economic impact) than a specific neck exercise program alone or a general aerobic exercise program alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Neck Pain

Currently open trials in the same condition.

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04749823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing